Editing Clozapine (section)

=== Severe personality disorders ===
Clozapine is also used in [[borderline personality disorder]] and a [[randomized controlled trial]] is underway.<ref>{{cite journal | vauthors = Gartlehner G, Crotty K, Kennedy S, Edlund MJ, Ali R, Siddiqui M, Fortman R, Wines R, Persad E, Viswanathan M | title = Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis | journal = CNS Drugs | volume = 35 | issue = 10 | pages = 1053–1067 | date = October 2021 | pmid = 34495494 | pmc = 8478737 | doi = 10.26226/morressier.59d4913bd462b8029238a351 }}</ref><ref>{{cite journal | vauthors = Beri A, Boydell J | title = Clozapine in borderline personality disorder: a review of the evidence | journal = Annals of Clinical Psychiatry | volume = 26 | issue = 2 | pages = 139–144 | date = May 2014 | pmid = 24812651 }}</ref><ref>{{cite journal | vauthors = Frogley C, Anagnostakis K, Mitchell S, Mason F, Taylor D, Dickens G, Picchioni MM | title = A case series of clozapine for borderline personality disorder | journal = Annals of Clinical Psychiatry | volume = 25 | issue = 2 | pages = 125–134 | date = May 2013 | pmid = 23638443 }}</ref><ref>{{cite journal | vauthors = Dickens GL, Frogley C, Mason F, Anagnostakis K, Picchioni MM | title = Experiences of women in secure care who have been prescribed clozapine for borderline personality disorder | journal = Borderline Personality Disorder and Emotion Dysregulation | volume = 3 | issue = 1 | pages = 12 | date = 7 October 2016 | pmid = 27761261 | pmc = 5055694 | doi = 10.1186/s40479-016-0049-x | doi-access = free }}</ref><ref name="Haw_2011">{{cite journal | vauthors = Haw C, Stubbs J | title = Medication for borderline personality disorder: a survey at a secure hospital | journal = International Journal of Psychiatry in Clinical Practice | volume = 15 | issue = 4 | pages = 280–285 | date = November 2011 | pmid = 22122000 | doi = 10.3109/13651501.2011.590211 | s2cid = 43305 }}</ref><ref>{{cite journal | vauthors = Rohde C, Polcwiartek C, Correll CU, Nielsen J | title = Real-World Effectiveness of Clozapine for Borderline Personality Disorder: Results From a 2-Year Mirror-Image Study | journal = Journal of Personality Disorders | volume = 32 | issue = 6 | pages = 823–837 | date = December 2018 | pmid = 29120277 | doi = 10.1521/pedi_2017_31_328 | s2cid = 26203378 }}</ref><ref>{{cite journal | vauthors = Stoffers-Winterling J, Storebø OJ, Lieb K | title = Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies | journal = Current Psychiatry Reports | volume = 22 | issue = 8 | pages = 37 | date = June 2020 | pmid = 32504127 | pmc = 7275094 | doi = 10.1007/s11920-020-01164-1 }}</ref><ref name="Swinton_2001">{{cite journal|vauthors=Swinton M|date=January 2001|title=Clozapine in severe borderline personality disorder|journal=The Journal of Forensic Psychiatry|language=en|volume=12|issue=3|pages=580–591|doi=10.1080/09585180110091994|issn=0958-5184|s2cid=144701732}}</ref><ref>{{cite web|title=NIHR Funding and Awards Search Website|url=https://fundingawards.nihr.ac.uk/award/16/157/02|access-date=14 September 2021|website=fundingawards.nihr.ac.uk}}</ref>

{{clear}}